KR101374649B1 - 가금류의 병원성 대장균의 병원성 인자를 발현하는 살모넬라균을 포함하는 가금류의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물. - Google Patents
가금류의 병원성 대장균의 병원성 인자를 발현하는 살모넬라균을 포함하는 가금류의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물. Download PDFInfo
- Publication number
- KR101374649B1 KR101374649B1 KR1020110073226A KR20110073226A KR101374649B1 KR 101374649 B1 KR101374649 B1 KR 101374649B1 KR 1020110073226 A KR1020110073226 A KR 1020110073226A KR 20110073226 A KR20110073226 A KR 20110073226A KR 101374649 B1 KR101374649 B1 KR 101374649B1
- Authority
- KR
- South Korea
- Prior art keywords
- poultry
- vaccine
- group
- salmonella
- escherichia coli
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 86
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 68
- 244000144977 poultry Species 0.000 title claims abstract description 62
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 60
- 241000607142 Salmonella Species 0.000 title claims abstract description 32
- 230000002238 attenuated effect Effects 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 239000000304 virulence factor Substances 0.000 title 1
- 230000007923 virulence factor Effects 0.000 title 1
- 238000011081 inoculation Methods 0.000 claims abstract description 54
- 230000028993 immune response Effects 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 19
- 230000001965 increasing effect Effects 0.000 claims abstract description 17
- 108091007433 antigens Proteins 0.000 claims description 37
- 102000036639 antigens Human genes 0.000 claims description 37
- 239000000427 antigen Substances 0.000 claims description 36
- 241001442654 Percnon planissimum Species 0.000 claims description 31
- 101150043148 iutA gene Proteins 0.000 claims description 30
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims description 22
- 101150090348 atpC gene Proteins 0.000 claims description 22
- 101150094741 eltB gene Proteins 0.000 claims description 13
- 241000287828 Gallus gallus Species 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 101100500479 Hafnia alvei eaeA gene Proteins 0.000 claims description 9
- 101150107911 eae gene Proteins 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 101100502108 Escherichia coli f17aG gene Proteins 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 101710167241 Intimin Proteins 0.000 claims description 4
- 108010000462 aerobactin receptor Proteins 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 241000286209 Phasianidae Species 0.000 claims description 3
- 241000272525 Anas platyrhynchos Species 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 2
- 235000013594 poultry meat Nutrition 0.000 description 46
- 238000002255 vaccination Methods 0.000 description 33
- 230000004044 response Effects 0.000 description 22
- 208000015181 infectious disease Diseases 0.000 description 19
- 230000003902 lesion Effects 0.000 description 19
- 235000013601 eggs Nutrition 0.000 description 18
- 230000007123 defense Effects 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 210000004698 lymphocyte Anatomy 0.000 description 14
- 241000588722 Escherichia Species 0.000 description 12
- 239000000725 suspension Substances 0.000 description 11
- 102000000588 Interleukin-2 Human genes 0.000 description 9
- 108010002350 Interleukin-2 Proteins 0.000 description 9
- 102000004889 Interleukin-6 Human genes 0.000 description 9
- 108090001005 Interleukin-6 Proteins 0.000 description 9
- 229940100601 interleukin-6 Drugs 0.000 description 9
- 230000035755 proliferation Effects 0.000 description 9
- 230000002708 enhancing effect Effects 0.000 description 8
- 230000036039 immunity Effects 0.000 description 8
- 230000001575 pathological effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000002093 peripheral effect Effects 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 7
- 230000003248 secreting effect Effects 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 230000004584 weight gain Effects 0.000 description 7
- 235000019786 weight gain Nutrition 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 6
- 108010074328 Interferon-gamma Proteins 0.000 description 6
- 230000007969 cellular immunity Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 210000000813 small intestine Anatomy 0.000 description 6
- 241000271566 Aves Species 0.000 description 5
- 206010015548 Euthanasia Diseases 0.000 description 5
- 102100037850 Interferon gamma Human genes 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 101100057358 Escherichia coli (strain K12) atpA gene Proteins 0.000 description 4
- 101150070197 F7-2 gene Proteins 0.000 description 4
- 101100084009 Pediococcus acidilactici pedA gene Proteins 0.000 description 4
- 101100226151 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) estA gene Proteins 0.000 description 4
- 101100185373 Streptococcus pneumoniae psaA gene Proteins 0.000 description 4
- 210000004712 air sac Anatomy 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 101150070717 papA gene Proteins 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 210000000612 antigen-presenting cell Anatomy 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000002011 intestinal secretion Anatomy 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000007918 pathogenicity Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 101150043276 Lon gene Proteins 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 206010039438 Salmonella Infections Diseases 0.000 description 2
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000021053 average weight gain Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 239000006153 eosin methylene blue Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229940031348 multivalent vaccine Drugs 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010039447 salmonellosis Diseases 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000590988 Danainae Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241001076388 Fimbria Species 0.000 description 1
- 101000599932 Gallus gallus Interferon gamma Proteins 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 208000010728 Meckel diverticulum Diseases 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000269435 Rana <genus> Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 241000607132 Salmonella enterica subsp. enterica serovar Gallinarum Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 229940124842 Salmonella vaccine Drugs 0.000 description 1
- 108091003202 SecA Proteins Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025609 Urogenital disease Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010066969 Vitello-intestinal duct remnant Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 101150107204 asd gene Proteins 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229960001506 brilliant green Drugs 0.000 description 1
- HXCILVUBKWANLN-UHFFFAOYSA-N brilliant green cation Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 HXCILVUBKWANLN-UHFFFAOYSA-N 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 101150075335 cpxR gene Proteins 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 230000016379 mucosal immune response Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012335 pathological evaluation Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 108010087967 type I signal peptidase Proteins 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000012418 validation experiment Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110073226A KR101374649B1 (ko) | 2011-07-22 | 2011-07-22 | 가금류의 병원성 대장균의 병원성 인자를 발현하는 살모넬라균을 포함하는 가금류의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물. |
| PCT/KR2012/005860 WO2013015586A2 (fr) | 2011-07-22 | 2012-07-23 | Composition de vaccin destinée à prévenir et à traiter la colibacillose et la salmonellose chez la volaille, contenant une souche de salmonelle exprimant des facteurs de virulence pathogènes d'escherichia coli de volaille |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110073226A KR101374649B1 (ko) | 2011-07-22 | 2011-07-22 | 가금류의 병원성 대장균의 병원성 인자를 발현하는 살모넬라균을 포함하는 가금류의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20130011809A KR20130011809A (ko) | 2013-01-30 |
| KR101374649B1 true KR101374649B1 (ko) | 2014-03-17 |
Family
ID=47601634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020110073226A KR101374649B1 (ko) | 2011-07-22 | 2011-07-22 | 가금류의 병원성 대장균의 병원성 인자를 발현하는 살모넬라균을 포함하는 가금류의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물. |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR101374649B1 (fr) |
| WO (1) | WO2013015586A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190070457A (ko) | 2017-12-13 | 2019-06-21 | 주식회사 오투파워 | 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101518872B1 (ko) * | 2013-05-14 | 2015-05-22 | 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) | 가금의 세균성 전신성 질병 원인균 진단용 프라이머 세트 및 상기 프라이머 세트를 포함하는 진단 키트 |
| KR101856736B1 (ko) * | 2016-02-29 | 2018-05-11 | (주)비손바이오로직스 | 가금티푸스 및 살모넬라증 예방을 위한 내독소가 감소된 살모넬라 3가 불활화 백신 조성물 |
| CN108992669B (zh) * | 2018-08-27 | 2022-03-22 | 广州汇高生物科技有限公司 | 防治呼吸道感染的复合卵黄抗体组合物、雾化吸入溶液剂及制备工艺与应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080105099A (ko) * | 2008-09-22 | 2008-12-03 | 브리제 유니버시타이트 브루셀 | 약독화 살모넬라 생백신 |
| KR20110023502A (ko) * | 2009-08-31 | 2011-03-08 | 전북대학교산학협력단 | 소의 병원성 대장균의 부착인자가 형질전환된 약독화 살모넬라균 변이주 및 이를 포함하는 소의 대장균증 및 살모넬라균증의 예방 및 치료용 백신조성물 |
-
2011
- 2011-07-22 KR KR1020110073226A patent/KR101374649B1/ko active IP Right Grant
-
2012
- 2012-07-23 WO PCT/KR2012/005860 patent/WO2013015586A2/fr active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080105099A (ko) * | 2008-09-22 | 2008-12-03 | 브리제 유니버시타이트 브루셀 | 약독화 살모넬라 생백신 |
| KR20110023502A (ko) * | 2009-08-31 | 2011-03-08 | 전북대학교산학협력단 | 소의 병원성 대장균의 부착인자가 형질전환된 약독화 살모넬라균 변이주 및 이를 포함하는 소의 대장균증 및 살모넬라균증의 예방 및 치료용 백신조성물 |
Non-Patent Citations (3)
| Title |
|---|
| 오인경, "닭대장균증 항원 유전자 재조합 살모넬라 생백신을 이용한 전신 및 점막면역 반응유도", 전북대학교 수의과대학 대학원 학위논문, 2007 * |
| 차우다리아툴(Chaudhari Atul A.), 전북대학교 수의학과 대학원 박사학위 논문, 2010. * |
| 차우다리아툴(Chaudhari Atul A.), 전북대학교 수의학과 대학원 박사학위 논문, 2010.* |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190070457A (ko) | 2017-12-13 | 2019-06-21 | 주식회사 오투파워 | 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013015586A9 (fr) | 2013-04-04 |
| WO2013015586A3 (fr) | 2013-05-23 |
| KR20130011809A (ko) | 2013-01-30 |
| WO2013015586A2 (fr) | 2013-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ghunaim et al. | Advances in vaccination against avian pathogenic Escherichia coli respiratory disease: potentials and limitations | |
| BRPI0615593A2 (pt) | liberação bacteriana de polipeptìdeos biologicamente ativos | |
| US20210145954A1 (en) | Method of reducing egg contamination | |
| CN105142653A (zh) | 增强对肠病原体免疫应答的组合物和方法 | |
| JPH07206705A (ja) | 生インオボ（ｉｎ ｏｖｏ）ワクチン | |
| KR101374649B1 (ko) | 가금류의 병원성 대장균의 병원성 인자를 발현하는 살모넬라균을 포함하는 가금류의 병원성 대장균증 및 살모넬라균증의 예방 및 치료용 백신 조성물. | |
| KR101150318B1 (ko) | 이. 콜라이 및 살모넬라에 대한 조류 배합 백신 | |
| US20190322707A1 (en) | Mutated Salmonella Enterica | |
| Roland et al. | Expression of Escherichia coli antigens in Salmonella typhimurium as a vaccine to prevent airsacculitis in chickens | |
| KR100954175B1 (ko) | 조류 질병을 유발하는 신규한 박테리아 및 그로부터 유래된 백신 | |
| KR102066545B1 (ko) | 신규한 살모넬라 타이피뮤리움 균주 및 이를 포함하는 백신 조성물 | |
| KR20180105945A (ko) | 신규한 살모넬라 타이피뮤리움 균주 및 이를 포함하는 백신 조성물 | |
| KR20120129777A (ko) | 약독화, 면역강화 살모넬라 엔테리티디스의 변이균주를 포함하는 살모넬라증 예방용 생균 백신 조성물 | |
| KR101031376B1 (ko) | 살모넬라 엔테리티디스 감염 예방용 불활화 백신 | |
| KR101856736B1 (ko) | 가금티푸스 및 살모넬라증 예방을 위한 내독소가 감소된 살모넬라 3가 불활화 백신 조성물 | |
| JP2008054614A (ja) | 鶏大腸菌由来弱毒変異株、鶏大腸菌対策用ワクチン、免疫方法及び鶏用ワクチンベクター | |
| US20030175835A1 (en) | Pathogen for bacterial poultry disease | |
| CN116836900A (zh) | 肠炎沙门菌ryhB-1和sopE双基因缺失株及其作为减毒疫苗候选株的应用 | |
| KR101371355B1 (ko) | 생물형 면역증강제를 이용한 경구용 가금티푸스 백신 조성물 | |
| Mansour et al. | EVALUATION OF COMMERCIAL ESCHERICHIA COLI VACCINE IN BROILER CHICKENS | |
| Zhao et al. | The peptidoglycan-associated lipoprotein gene mutant elicits robust immunological defense in mice against Salmonella enteritidis | |
| EP2911688B1 (fr) | Vaccins de protection croisée contre la salmonelle | |
| Hannan et al. | A study on the efficacy of inactivated avian E. coli vaccine in layer chicks | |
| Elsheikha et al. | Therapeutic efficacy of chicken egg yolk immunoglobulins against Mycoplasma gallisepticum infection in chickens | |
| CN116496367A (zh) | 一种马链球菌马亚种se071780-01939蛋白、疫苗及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| AMND | Amendment | ||
| X701 | Decision to grant (after re-examination) | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20170221 Year of fee payment: 4 |
|
| FPAY | Annual fee payment |
Payment date: 20180208 Year of fee payment: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20190326 Year of fee payment: 6 |